One Ascent Wealth Management LLC Uni Qure N.V. Transaction History

One Ascent Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$20.24 - $36.01 $274,312 - $488,043	-13,553 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$26.01 - $38.22 $193,384 - $284,165	-7,435 Reduced 35.43%	13,553 $434,000
Q1 2021 Apr 27, 2021	BUY	$29.24 - $42.03 $206,288 - $296,521	7,055 Added 50.64%	20,988 $707,000
Q4 2020 Feb 08, 2021	BUY	$35.35 - $50.67 $492,531 - $705,985	13,933 New	13,933 $503,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of One Ascent Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Wealth Management LLC with notifications on news.